Emil Frei III, a cancer researcher who in the 1950s combined multiple chemotherapy drugs to treat childhood leukemia, has died at the age of 89.
The Scientist
Most Recent
Genetic changes that may initiate childhood leukemia could originate while the baby is still in utero.
T-cells engineered to attack B-cells sent adults’ acute leukemia into remission.
A new report from the World Health Organization predicts only very minimal increases in cancer risk for residents in the vicinity of the nuclear disaster.
Viral DNA in mice genomes may lead to cancer in immune-compromised animals.
Exposure to doses of radiation used in some diagnostics in childhood can triple the risk of brain cancer and leukemia as an adult.
A transition-state mimic has the power to bind an enzyme at its tipping point as strongly as any available inhibitor and more strongly than most, preventing enzymatic activity. In order to replicate the structure of an enzyme’s transition state, whic
Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.
Telomeres have been linked to numerous diseases over the years, but how exactly short telomeres cause diseases and how medicine can prevent telomere erosion are still up for debate.
A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
